Douglas B. Flieder

Survival Analysis of 200 Pulmonary Neuroendocrine Tumors With Clarification of Criteria for Atypical Carcinoid and Its Separation From Typical Carcinoid

William D. Travis, Walter L. Rush, Douglas B. Flieder et al. · The American Journal of Surgical Pathology · 1998 · 806 citations

Medicine, Oncology, Endocrine Oncology +16

A Prospective, Multi-institutional, Pathologist-Based Assessment of 4 Immunohistochemistry Assays for PD-L1 Expression in Non–Small Cell Lung Cancer

David L. Rimm, Gang Han, Janis M. Taube et al. · JAMA Oncology · 2017 · 762 citations

Medicine, Oncology, Pathology +17

Early Lung Cancer Action Project

Claudia I. Henschke, David P. Naidich, David F. Yankelevitz et al. · Cancer · 2001 · 490 citations · Full text

Medicine, Oncology, Radiology +15

Survival Impact of Increasing Time to Treatment Initiation for Patients With Head and Neck Cancer in the United States

Colin T. Murphy, Thomas J. Galloway, Elizabeth A. Handorf et al. · Journal of Clinical Oncology · 2015 · 428 citations

Public Health, Biostatistics, Oncology +15

Diagnosis of Lung Cancer in Small Biopsies and Cytology: Implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification

William D. Travis, Élisabeth Brambilla, Masayuki Noguchi et al. · Archives of Pathology & Laboratory Medicine · 2012 · 414 citations · Full text

Medicine, Oncology, Pathology +17